1887
Volume 2012, Issue 1
  • ISSN: 2305-7823
  • E-ISSN:

There is no abstract available for this article.

Loading

Article metrics loading...

/content/journals/10.5339/gcsp.2012.8
2012-08-27
2019-08-18
Loading full text...

Full text loading...

/deliver/fulltext/gcsp/2012/1/gcsp.2012.8.html?itemId=/content/journals/10.5339/gcsp.2012.8&mimeType=html&fmt=ahah

References

  1. [1]. Lloyd-Jones   DM, , Larson   MG, and Leip   EP   et al.   Lifetime risk for developing congestive heart failure. . Circulation . 2002; ;106: : 3068– 3072 .
    [Google Scholar]
  2. [2]. Roger   VL, , Go   AS, and Lloyd-Jones   DM   et al.   Heart disease and stroke statistics 2011 update: A report from the American HeartAssociation. . Circulation . 2011; ;123: : e18– e209 .
    [Google Scholar]
  3. [3]. Maron   BJ, , Towbin   JA, and Thiene   G   et al.   Contemporary definitions and classification of the cardiomyopathies. An AmericanHeart Association scientific statement from the Council on Clinical Cardiology, HeartFailure and Transplantation Committee; Quality of Care and Outcomes Research andFunctional Genomics and Translational Biology Interdisciplinary Working Groups;and Council on Epidemiology and Prevention. . Circulation . 2006; ;113: : 1807– 1816 .
    [Google Scholar]
  4. [4]. Petretta   M., , Pirozzi   F., , Sasso   L., , Paglia   A., and Bonaduce   D. Review and metaanalysis of the frequency of familial dilated cardiomyoapthy. . Am JCardiol . 2011; ;108: : 1171– 1176 .
    [Google Scholar]
  5. [5]. Lee   DS, , Pencina   MJ, and Benjamin   EJ   et al.   Association of parental heart failure with risk of heart failure in offspring. . N Engl JMed . 2006; ;355: : 138– 147 .
    [Google Scholar]
  6. [6]. Hershberger   RE., , Lindenfeld   J., , Mestroni   L., , Seidman   CE., , Taylor   MR., and Towbin   JA. Genetic evaluation of cardiomyopathy – a Heart Failure Society of America PracticeGuideline. . J Cardiac Fail . 2009; ;15: : 83– 97 .
    [Google Scholar]
  7. [7]. Van Berlo   JH, , de Voogt   WG, and van der Kooi   AJ   et al.   Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: dolamin A/C mutations portend a high risk of sudden death?. . J Mol Med . 2005; ;83: : 79– 83 .
    [Google Scholar]
  8. [8]. Pasotti   M, , Klersy   C, and Pilotto   A   et al.   Long-term outcome and risk stratification in dilated cardiolaminopathies. . J Am CollCardiol . 2008; ;52: : 1250– 1260 .
    [Google Scholar]
  9. [9]. Fatkin   D., , Otway   R., and Richmond   Z. Genetics of dilated cardiomyopathy. . Heart Fail Clin . 2010; ;6: : 129– 140 .
    [Google Scholar]
  10. [10]. Hershberger   RE., and Siegfried   JD. Update 2011: Clinical and genetic issues in familial dilated cardiomyopathy. . J AmColl Cardiol . 2011; ;57: : 1641– 1649 .
    [Google Scholar]
  11. [11]. Fatkin   D, , MacRae   C, and Sasaki   T   et al.   Missense mutations in the rod domain of the lamin A/C gene as causes of dilatedcardiomyopathy and conduction-system disease. . N Engl J Med . 1999; ;341: : 1715– 1724 .
    [Google Scholar]
  12. [12]. McNair   WP., , Ku   L., , Taylor   MR., , Fain   PR., , Dao   D., , Wolfel   E., and Mestroni   L. Familial Cardiomyopathy Registry Research Group. SCN5A mutation associatedwith dilated cardiomyopathy, conduction disorder, and arrhythmia. . Circulation . 2004; ;110: : 2163– 2167 .
    [Google Scholar]
  13. [13]. Olson   TM., , Michels   VV., , Ballew   JD., , Reyna   SP., , Karst   ML., , Herron   KJ., , Horton   SC., , Rodeheffer   RJ., and Anderson   JL. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. . JAMA . 2005; ;293: : 447– 454 .
    [Google Scholar]
  14. [14]. Arbustini   E, , Diegoli   M, and Morbini   P   et al.   Prevalence and characteristics of dystrophin defects in adult male patients withdilated cardiomyopathy. . J Am Coll Cardiol . 2000; ;35: : 7 , 1760– 1768 .
    [Google Scholar]
  15. [15]. Feng   J, , Yan   J, and Buzin   CH   et al.   Comprehensive mutation screening of the dystrophin gene in patients withnonsyndromic X-linked dilated cardiomyopathy. . J Am Coll Cardiol . 2002; ;40: : 1120– 1124 .
    [Google Scholar]
  16. [16]. Schonberger   J, , Wang   L, and Shin   JT   et al.   Mutation in the transcriptional coactivator EYA4 causes dilated cardiomyopathy andsensorineural hearing loss. . Nat Genet . 2005; ;37: : 418– 422 .
    [Google Scholar]
  17. [17]. Gerull   B, , Gramlich   M, and Atherton   J   et al.   Mutations of TTN, encoding the giant muscle filament titin, cause familial dilatedcardiomyopathy. . Nat Genet . 2002; ;30: : 201– 204 .
    [Google Scholar]
  18. [18]. Itoh-Satoh   M, , Hayashi   T, and Nishi   T   et al.   Titin mutations as the molecular basis for dilated cardiomyopathy. . Biochem BiophysRes Commun . 2002; ;291: : 385– 393 .
    [Google Scholar]
  19. [19]. Herman   DS, , Lam   L, and Taylor   MR   et al.   Truncations of titin causing dilated cardiomyopathy. . N Engl J Med . 2012; ;366: : 619– 628 .
    [Google Scholar]
  20. [20]. Fatkin   D., and Graham   RM. Molecular mechanisms of inherited cardiomyopathies. . Physiol Rev . 2002; ;82: : 945– 980 .
    [Google Scholar]
  21. [21]. Watkins   H., , Ashrafian   H., and Redwood   C. Inherited cardiomyopathies. . N Engl J Med . 2011; ;364: : 1643– 1656 .
    [Google Scholar]
  22. [22]. Baig   MK., , Goldman   JH., , Caforio   AL., , Coonar   AS., , Keeling   PJ., and McKenna   WJ. Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomaticrelatives and may represent early disease. . J Am Coll Cardiol . 1998; ;31: : 195– 201 .
    [Google Scholar]
  23. [23]. Crispell   KA., , Wray   A., , Ni   H., , Nauman   DJ., and Hershberger   RE. Clinical profiles of four large pedigrees with familial dilated cardiomyopathy.Preliminary recommendations for clinical practice. . J Am Coll Cardiol . 1999; ;34: : 837– 847 .
    [Google Scholar]
  24. [24]. Michels   VV., , Olson   TM., , Miller   FA., , Ballman   KV., , Rosales   AG., and Driscoll   DJ. Frequency of development of idiopathic dilated cardiomyopathy among relatives ofpatients with idiopathic dilated cardiomyopathy. . Am J Cardiol . 2003; ;91: : 1389– 1392 .
    [Google Scholar]
  25. [25]. Mahon   NG., , Murphy   RT., , MacRae   CA., , Caforio   AL., , Elliott   PM., and McKenna   WJ. Echocardiographic evaluation in asymptomatic relatives of patients with dilatedcardiomyopathy reveals preclinical disease. . Ann Intern Med . 2005; ;143: : 108– 115 .
    [Google Scholar]
  26. [26]. Fatkin   D, , Yeoh   T, and Hayward   CS   et al.   Evaluation of left ventricular enlargement as a marker of early disease in familialdilated cardiomyopathy. . Circ Cardiovasc Genet . 2011; ;4: : 342– 348 .
    [Google Scholar]
  27. [27]. Matsumura   Y., , Elliott   PM., , Mahon   NG., , Virdee   MS., , Doi   Y., and McKenna   WJ. Familial dilated cardiomyopathy: assessment of left ventricular systolic and diastolicfunction using Doppler tissue imaging in asymptomatic relatives with left ventricularenlargement. . Heart . 2006; ;92: : 405– 406 .
    [Google Scholar]
  28. [28]. Sakata   K, , Ino   H, and Fujino   N   et al.   Exercise-induced systolic dysfunction in patients with non-obstructive hypertrophiccardiomyopathy and mutations in the cardiac troponin genes. . Heart . 2008; ;94: : 1282– 1287 .
    [Google Scholar]
  29. [29]. McDonagh   TA, , Robb   SD, and Murdoch   DR   et al.   Biochemical detection of left ventricular systolic dysfunction. . Lancet . 1998; ;351: : 9– 13 .
    [Google Scholar]
  30. [30]. Caforio   AL, , Mahon   NG, and Baig   MK   et al.   Prospective familial assessment in dilated cardiomyopathy. Cardiac autoantibodiespredict disease development in asymptomatic relatives. . Circulation . 2007; ;115: : 76– 83 .
    [Google Scholar]
  31. [31]. Koikkalainen   JR, , Antial   M, and Lotjonen   JMP   et al.   Early familial dilated cardiomyopathy: identification with determination ofdisease state parameter from cine MR image data. . Radiology . 2008; ;249: : 88– 96 .
    [Google Scholar]
  32. [32]. Chandar   S, , Yeo   LS, and Leimena   C   et al.   Effects of mechanical stress and carvedilol in lamin A/C-deficient dilatedcardiomyopathy. . Circ Res . 2010; ;106: : 573– 582 .
    [Google Scholar]
  33. [33]. Muchir   A., , Shan   J., , Bonne   G., , Lehnart   SE., and Worman   HJ. Inhibition of extracellular signal-regulate kinase signaling to prevent cardiomyopathycaused by mutation in the gene encoding A-type lamins. . Hum Mol Genet . 2009; ;18: : 241– 247 .
    [Google Scholar]
  34. [34]. Stenson   PD, , Ball   EV, and Howells   K   et al.   The Human Gene Mutation database: providing a comprehensive central mutationdatabase for molecular diagnostics and personalized genomics. . Hum Genomics . 2009; ;4: : 69– 72 .
    [Google Scholar]
  35. [35]. Kryukov   GV., , Pennacchio   LA., and Sunyaev   SR. Most rare missense alleles are deleterious in humans: implications for complexdisease and association studies. . Am J Hum Genet . 2007; ;80: : 727– 739 .
    [Google Scholar]
  36. [36]. Bamshad   MJ, , Ng   SB, and Bigham   AW   et al.   Exome sequencing as a tool for Mendelian disease gene discovery. . Nat Rev Genet . 2011; ;12: : 745– 755 .
    [Google Scholar]
  37. [37]. The 1000 Genomes Project Consortium   . A map of human genome variation from population-scale sequencing. . Nature . 2010; ;467: : 1061– 1073 .
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/gcsp.2012.8
Loading
/content/journals/10.5339/gcsp.2012.8
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error